Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy.
Nat Commun. 2021 Jan 12;12(1):346. doi: 10.1038/s41467-020-20600-7.
Nat Commun. 2021.
PMID: 33436641
Free PMC article.
Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance.
Liu J, Rebecca VW, Kossenkov AV, Connelly T, Liu Q, Gutierrez A, Xiao M, Li L, Zhang G, Samarkina A, Zayasbazan D, Zhang J, Cheng C, Wei Z, Alicea GM, Fukunaga-Kalabis M, Krepler C, Aza-Blanc P, Yang CC, Delvadia B, Tong C, Huang Y, Delvadia M, Morias AS, Sproesser K, Brafford P, Wang JX, Beqiri M, Somasundaram R, Vultur A, Hristova DM, Wu LW, Lu Y, Mills GB, Xu W, Karakousis GC, Xu X, Schuchter LM, Mitchell TC, Amaravadi RK, Kwong LN, Frederick DT, Boland GM, Salvino JM, Speicher DW, Flaherty KT, Ronai ZA, Herlyn M.
Liu J, et al. Among authors: samarkina a.
Cancer Res. 2021 Oct 15;81(20):5230-5241. doi: 10.1158/0008-5472.CAN-20-1496. Epub 2021 Aug 30.
Cancer Res. 2021.
PMID: 34462276
Free PMC article.
Item in Clipboard
NUMB as a Therapeutic Target for Melanoma.
Hristova DM, Fukumoto T, Takemori C, Gao L, Hua X, Wang JX, Li L, Beqiri M, Watters A, Vultur A, Gimie Y, Rebecca V, Samarkina A, Jimbo H, Nishigori C, Zhang J, Cheng C, Wei Z, Somasundaram R, Fukunaga-Kalabis M, Herlyn M.
Hristova DM, et al. Among authors: samarkina a.
J Invest Dermatol. 2022 Jul;142(7):1882-1892.e5. doi: 10.1016/j.jid.2021.11.027. Epub 2021 Dec 7.
J Invest Dermatol. 2022.
PMID: 34883044
Free PMC article.
Item in Clipboard
Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis.
Ma M, Ghosh S, Tavernari D, Katarkar A, Clocchiatti A, Mazzeo L, Samarkina A, Epiney J, Yu YR, Ho PC, Levesque MP, Özdemir BC, Ciriello G, Dummer R, Dotto GP.
Ma M, et al. Among authors: samarkina a.
J Exp Med. 2021 Feb 1;218(2):e20201137. doi: 10.1084/jem.20201137.
J Exp Med. 2021.
PMID: 33112375
Free PMC article.
Item in Clipboard
ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation.
Mazzeo L, Ghosh S, Di Cicco E, Isma J, Tavernari D, Samarkina A, Ostano P, Youssef MK, Simon C, Dotto GP.
Mazzeo L, et al. Among authors: samarkina a.
Nat Commun. 2024 Feb 3;15(1):1038. doi: 10.1038/s41467-024-45308-w.
Nat Commun. 2024.
PMID: 38310103
Free PMC article.
Item in Clipboard
Androgen receptor is a determinant of melanoma targeted drug resistance.
Samarkina A, Youssef MK, Ostano P, Ghosh S, Ma M, Tassone B, Proust T, Chiorino G, Levesque MP, Goruppi S, Dotto GP.
Samarkina A, et al.
Nat Commun. 2023 Oct 14;14(1):6498. doi: 10.1038/s41467-023-42239-w.
Nat Commun. 2023.
PMID: 37838724
Free PMC article.
Item in Clipboard
FimH and Type 1 Pili Mediated Tumor Cell Cytotoxicity by Uropathogenic Escherichia coli In Vitro.
Van Eyssen SR, Samarkina A, Isbilen O, Zeden MS, Volkan E.
Van Eyssen SR, et al. Among authors: samarkina a.
Pathogens. 2023 May 23;12(6):751. doi: 10.3390/pathogens12060751.
Pathogens. 2023.
PMID: 37375441
Free PMC article.
Item in Clipboard
Cite
Cite